Intercure Ltd. - ordinary shares (INCR)

InterCure Ltd. (NASDAQ: INCR) acquires Botanico Ltd., known as ISHI, to strengthen its global cannabis portfolio.

InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s recent decriminalization have ignited optimism within the sector.

The potential rescheduling of cannabis in the U.S.

"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.

Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023,

  Wednesday's session saw 43 companies set new 52-week lows.

Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQ: INCR) for $35 million.

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million) representing 22% growth YoY and up 1% sequenti

Cannabis stocks shot up in Thursday's pre-market and are holding.

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership.

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P 500, also rose, gaining, 0.17% to 4,116.15.